Tag: Ampio Pharmaceuticals

  • Healthcare Top Losers: VIVUS, Inc. (NASDAQ:VVUS), Cesca Therapeutics (NASDAQ:KOOL), Stereotaxis Inc (NASDAQ:STXS), Ampio Pharmaceuticals Inc (NYSEMKT:AMPE)

    VIVUS, Inc. (NASDAQ:VVUS) can still make a turnaround from its current post-earnings drop, the risks to this situation are becoming more prominent than the potential gains. It would seem that VIVUS is going to have a much more difficult time in becoming the next great biotech turnaround stock. VIVUS, Inc. (NASDAQ:VVUS) stock opened at $5.77 in last session, and closed at $5.86, while the day range of VVUS stock is $5.77-$6.24.The stock showed a negative weekly performance of -18.61%.

    Cesca Therapeutics Inc (NASDAQ:KOOL), formerly known as ThermoGenesis Corp., announced that they have entered a supply agreement with Cook Medical. We have found the ideal partner in Cook Medical to supply catheters, angioplasty balloons and other interventional products for the AMIRST Phase 1b trial,” said Matthew Plavan, CEO, Cesca Therapeutics. Cesca Therapeutics Inc (NASDAQ:KOOL) stock opened at $2.40, in last session and closed at $2.21, by loosed -6.75%.The 52 week range was $0.71-$3.24.Company’s market capitalization is $44.29 million.

    Stereotaxis, Inc. (Nasdaq:STXS) announced that it has entered into a definitive agreement with Medix Japan, Inc. and Hokushin Medical Co. Ltd. to distribute its Niobe® Magnetic Navigation System for cardiac ablations in Japan. The agreement ensures sales and marketing coverage for Stereotaxis in an electrophysiology (EP) market performing approximately 47,000 procedures each year and expected to grow at an annual rate of 10% through 2018. Japan also represents one of the largest medical device markets globally, second to the U.S. Stereotaxis Inc (NASDAQ:STXS) stock loosed -5.80% and finished the last session at $5.52. The EPS of the stock remained -5.25.Company’s market capitalization is $106.71 million.

    Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) announced that it intends to offer 8,000,000 shares of its common stock in a proposed underwritten public offering. Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) stock opened the session at $8.70, and closed the session at $8.47. The 52 week range of the AMPE stock remained $3.60-$10.86 and the day range was $8.45-$9.10.